Allopurinol
Product Images NDC 53217-187
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 53217-187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Allopurinol Is A Structural Analogue Of The Natural Purine Base, Hypoxanthine. It Is An Inhibitor Of Xanthine Oxidase, The Enzyme Responsible For The Conversion Of Hypoxanthine To Xanthine And Of Xanthine To Uric Acid, The End Product Of Purine Metabolism In Man. Allopurinol Is Metabolized To The Corresponding Xanthine Analogue, Oxipurinol (alloxanthine), Which Also Is An Inhibitor Of Xanthine Oxidase. (Allopurinol Usp 2)
Image Description (Allopurinol Usp 3)
This is a description of a pharmaceutical product named ALLOPURINOL, USP which is in the form of a white round tablet with DAN score DAN 2 imprinted on one side and a 30 tabs imprint on the reverse side. Each tablet contains 100mg of ALLOPURINOL, USP as the active ingredient. This drug is a generic equivalent for ZYLOPRIM® and is packaged in a bottle of 30 tablets. The manufacturer of this drug is Watson Pharma Private Limited, India. It should be noted that dispensing this drug without a prescription is prohibited by federal law and it should be kept out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.